Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Korro Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
KRRO
Nasdaq
8731
https://www.korrobio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Korro Bio Inc
Korro Announces $70 Million Private Placement
- Apr 18th, 2024 12:30 pm
Korro to Participate in Upcoming Investor Conferences
- Apr 1st, 2024 8:01 pm
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress
- Mar 26th, 2024 8:01 pm
Korro to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 27th, 2024 1:00 pm
Private equity firms are Korro Bio, Inc.'s (NASDAQ:KRRO) biggest owners and were rewarded after market cap rose by US$161m last week
- Feb 6th, 2024 10:53 am
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
- Jan 18th, 2024 1:00 pm
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 1:00 pm
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
- Dec 7th, 2023 1:00 pm
Korro Bio Appoints Dr. Rachel Meyers to Board of Directors
- Nov 28th, 2023 1:00 pm
UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
- Nov 3rd, 2023 7:31 pm
Scroll